Jim Daly to Join Incyte Corporation (INCY) as Executive Vice President and Chief Commercial Officer

Jim Daly to Join Incyte Corporation (INCY) as Executive Vice President and Chief Commercial Officer

10/22/2012 9:32:09 AM

WILMINGTON, Del.--Incyte Corporation (Nasdaq:INCY) today announced that Jim Daly has joined Incyte as Executive Vice President and Chief Commercial Officer, reporting to Paul Friedman, M.D., Incyte's President and Chief Executive Officer. Formerly Senior Vice President, North America Commercial Operations at Amgen, Mr. Daly is joining Incyte effective today and will serve on the executive leadership team, assuming responsibility for Incyte's commercial organization, including sales, marketing and business development.

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.